Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shukuan Li

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Cancer Diagnosis & Prognosis|May 4, 2026
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|November 29, 2025
The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis|January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal CellsByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell CarcinomaTomoyuki Ishiguro, Toshihiko Sato, Qinghong Han, et al.
Anticancer Research|September 26, 2025
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of CancerByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Anticancer Research|August 28, 2025
Combinations of <i>Salmonella typhimurium</i> A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primatesZhijian Yang, Junhua Wang, Takayuki Yoshioka, et al.
Anticancer Research|January 30, 2026
Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine DependenceYuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Anticancer Research|March 27, 2026
The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer ParadigmYuta Miyashi, Kohei Mizuta, Tomoyuki Ishiguro, et al.
Anticancer Research|December 30, 2025
Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific VulnerabilityYuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancer Diagnosis & Prognosis|May 4, 2026
The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Anticancer Research|November 29, 2025
The Combination of Recombinant Methioninase and Low-dose Chloroquine Selectively Eradicates Colon-Cancer Cells Without Apparent Toxicity on Co-cultured Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis|January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal CellsByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell CarcinomaTomoyuki Ishiguro, Toshihiko Sato, Qinghong Han, et al.
Anticancer Research|September 26, 2025
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of CancerByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Anticancer Research|August 28, 2025
Combinations of <i>Salmonella typhimurium</i> A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primatesZhijian Yang, Junhua Wang, Takayuki Yoshioka, et al.
Anticancer Research|January 30, 2026
Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine DependenceYuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Anticancer Research|March 27, 2026
The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer ParadigmYuta Miyashi, Kohei Mizuta, Tomoyuki Ishiguro, et al.
Anticancer Research|December 30, 2025
Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific VulnerabilityYuta Miyashi, Kohei Mizuta, Yohei Asano, et al.
Pageof 6